About Us

Shoshana Lipson is the president of Hope in Pain, Inc. and the founder and Executive Director of Migraine Meanderings (a DBA of Hope in Pain) and Hope for Migraine community. She is a patient advocate, speaker, and writer with a passion to encourage, support, educate and inspire people with migraine to find purpose and value in the midst of chronic illness, and not give up hope. She has been living with migraine disease for most of her life as well as other comorbid conditions. Shoshana has a BDiv from Aberdeen University, Scotland, with post-graduate work in psychology, counseling and non-profit management. After having to stop full-time work in 2014, she started exploring how to use her non-profit and public speaking experience to help with migraine advocacy. 

Shoshana has a passion to touch people who are struggling with the physical and emotional effects of migraine through authentic and real-life sharing. Since 2018 she has built an online community of over 20,000 members on social media. Shoshana collaborates with various advocacy organization such as the Coalition for Headache and Migraine Patients (CHAMP) and the Headache and Migraine Policy Forum, as well as other organizations and leaders who advocate for people with migraine. She is also a contributing writer for Migraine.com and US Pain Foundation. 

Shoshana has been a speaker at several migraine and chronic pain events (e.g. the Association of Migraine Disorders Symposium, Healthy Women Roundtable, the American Journal of Managed Care, RetreatMigraine, Pharma & Patient USA, DIA Global, and the Therapeutic Pain Summit). She also consults and acts on an advisory basis for several medical device and pharmaceutical companies to help bridge the gap of communication between patients, HCPs and pharma.   

Peter (Pj) de Marigny has been a financial services professional for over 20 years and has worked as a consultant for company issuers. He is an experienced, sophisticated capital markets investment strategist who has worked both on buy side (asset manager, private equity, CFO, SFO) and sell side (brokerage, registered adviser, capital intro). He is adept in fund raising, writing pitch books, analytics, and strategy.

Pj has completed multiple professional educational programs including Wharton’s CPD Circle. He has an MBA in TQM, an MS in Banking and Financial Services Management, an MAT in Theology, and he is currently a PhD Education student at Talbot. 

Pj brings to Hope in Pain extensive experience in business development and sales, and acts in an advisory capacity for new initiatives and fundraising. 

Ralph Carmichael, Esq. has over 30 years of financial and management experience. He founded BŌNWRx Ltd, which makes complex spine surgery implants, built the company to a market value of over $500 million, and he holds many patents across numerous industries. In 1992, he started Carmichael & Company LLC, a merchant bank that managed over $6 billion in assets and advised on over $100 billion in transactions. He was a member of the investment committee of an international private equity fund that turned $384 million into over $1.8 billion in eight years. Prior to that, he was an executive at Bear, Stearns & Co., Inc. and an Associate at Cadwalader, Wickersham & Taft. 

Ralph is a frequent speaker at financial  industry events and is a recognized authority on exit strategies and liquidity alternatives for institutional investors. He also teaches finance courses at Michigan State University. Ralph has a B.A. and M.B.A. from Michigan State University (1985) and a J.D. from New York Law School (1989). He was a Law Review Editor and Clerk for the Hon. John E. Sprizzo, U.S. District Judge (SDNY).

Andree Kaminsky is a versatile business professional with proven success in diverse industries. She drives business results by leveraging an entrepreneurial mindset with well-honed skills in client relationship management, sales and marketing, customer service, patient advocacy, and social media management.

Andree brings 20 years experience with achievements in 4 distinct and unrelated industries, demonstrating her ability to rapidly learn and adapt while concurrently drawing upon highly transferable business skills.

Andree’s introduction to the migraine community came when she took on the role as the USA liaison for the clinical trial and FDA submission process for Theranica’s wearable acute migraine device, Nerivio in 2018. She has continued to work with Theranica.

Andree possesses a deft ability to build trust and credibility with a wide range of stakeholders, including colleagues, partners, healthcare practitioners, advocates, influencers, patients, consumers, and customers. She brings her business experience and passion for finding relief to the migraine community to this board position at Hope in Pain.